T1	Participants 73 108	advanced pancreatic cancer patients
T2	Participants 298 345	patients with advanced pancreatic cancer (APC).
T3	Participants 358 422	39 patients with APC, without thrombosis, receiving chemotherapy
T4	Participants 1523 1543	APC patients treated
